Patents by Inventor Abraham de la Cruz

Abraham de la Cruz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9492466
    Abstract: The present disclosure provides methods of treating, ameliorating, or preventing immune disorders, allergic disorders, or inflammatory disorders, or combinations thereof, or providing hepatoprotection in subject. In one aspect, the method comprises administering to a subject a therapeutically effective amount of a ?-hydroxy-?-aminophosphonate or ?-amino-?-aminophosphonate.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: November 15, 2016
    Assignee: Nucitec S.A. de C.V.
    Inventors: Ricardo Abraham De La Cruz Cordero, Jorge Luis Rosado Loria, Miguel Angel Duarte Vazquez, José Mario Ordóñez Palacios, Jorge Alberto Reyes Esparza, Maria de Lourdes Rodriguez Fragoso
  • Publication number: 20140107079
    Abstract: The present disclosure provides methods of treating, ameliorating, or preventing immune disorders, allergic disorders, or inflammatory disorders, or combinations thereof, or providing hepatoprotection in subject. In one aspect, the method comprises administering to a subject a therapeutically effective amount of a ?-hydroxy-?-aminophosphonate or ?-amino-?-aminophosphonate.
    Type: Application
    Filed: March 14, 2013
    Publication date: April 17, 2014
    Applicant: Nucites S.A. de C.V.
    Inventors: Ricardo Abraham De La Cruz Cordero, Jorge Luis Rosado Loria, Miguel Angel Duarte Vazquez, José Mario Ordóñez Palacios, Jorge Alberto Reyes Esparza, Maria de Lourdes Rodriguez Fragoso
  • Patent number: 8536362
    Abstract: The present invention provides ?-hydroxy-?-aminophosphonates, ?-amino-?-aminophosphonates, and analogs thereof that inhibit carnitine acyltransferases. The invention also provides compositions comprising these ?-hydroxy-?-aminophosphonates, ?-amino-?-aminophosphonates, and analogs, and methods of the use of such compounds and compositions in the treatment, amelioration or prevention of pathological conditions, diseases or disorders that are linked with fatty acid metabolism, such as non-insulin dependent diabetes or obesity. The invention also provides processes for the preparation of such compounds and compositions.
    Type: Grant
    Filed: March 22, 2012
    Date of Patent: September 17, 2013
    Assignee: Nucitec S.A. de C.V.
    Inventors: Ricardo Abraham De La Cruz Cordero, Miguel Ångel Duarte Vázquez, Jorge Luis Rosado Loria
  • Publication number: 20130079308
    Abstract: The present invention provides ?-hydroxy-?-aminophosphonates, ?-amino-?-aminophosphonates, and analogs thereof that inhibit carnitine acyltransferases. The invention also provides compositions comprising these ?-hydroxy-?-aminophosphonates, ?-amino-?-aminophosphonates, and analogs, and methods of the use of such compounds and compositions in the treatment, amelioration or prevention of pathological conditions, diseases or disorders that are linked with fatty acid metabolism, such as non-insulin dependent diabetes or obesity. The invention also provides processes for the preparation of such compounds and compositions.
    Type: Application
    Filed: March 22, 2012
    Publication date: March 28, 2013
    Applicant: Nucitec S.A. de C.V.
    Inventors: Ricardo Abraham De La Cruz Cordero, Miguel Ångel Duarte Vázquez, Jorge Luis Rosado Loria
  • Patent number: 8178515
    Abstract: The present invention provides ?-hydroxy-?-aminophosphonates, ?-amino-?-aminophosphonates, and analogs thereof that inhibit carnitine acyltransferases. The invention also provides compositions comprising these ?-hydroxy-?-aminophosphonates, ?-amino-?-aminophosphonates, and analogs, and methods of the use of such compounds and compositions in the treatment, amelioration or prevention of pathological conditions, diseases or disorders that are linked with fatty acid metabolism, such as non-insulin dependent diabetes or obesity. The invention also provides processes for the preparation of such compounds and compositions.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: May 15, 2012
    Assignee: Nucitec S.A. de C.V.
    Inventors: Ricardo Abraham De La Cruz Cordero, Miguel Angel Duarte-Vazquez, Jorge Luis Rosado Loria
  • Patent number: 8101881
    Abstract: An exhaust system for exhausting gases and molten debris caused by an electric arc within a switchgear. The exhaust system includes a switchgear having lower and upper compartments and an exhaust unit externally mounted to the switchgear. A wall panel of the switchgear includes blow out panels coinciding with openings in the lower compartment and corresponding ventilation flaps in a top surface of the exhaust unit to exhaust gas from the lower compartment out the blow out panels in a vertical direction, exiting through the flaps. The upper compartment includes ventilation flaps for exhausting gas in a vertical direction directly through the flaps and optionally through side-mounted blow out panels that communicate with the vertical vent path to the flaps in the top of the exhaust unit. A bus compartment in the exhaust unit includes a vent path to flaps in the top of the exhaust unit for exhausting gas produced by bus arcing.
    Type: Grant
    Filed: April 8, 2009
    Date of Patent: January 24, 2012
    Assignee: Schneider Electric USA, Inc.
    Inventors: Michael Miller, Abraham de la Cruz
  • Patent number: 7952857
    Abstract: An arc-resistant enclosure for electrical switchgear which includes solid front and back walls, a pair of solid side walls joined to the front and back walls, a ventilated roof joined to the side walls and the front and back walls, and a ventilated base joined to the side walls and the front and back walls. Internal partitions divide the space enclosed by the front, back, side, top and bottom walls into multiple compartments for housing different types of components. The ventilated base forms air-intake ports for admitting ambient air into a plurality of the compartments, and the ventilated roof forms air-exhaust ports for allowing air to be exhausted from the compartments. As air inside the enclosure is heated by the switchgear, the hot air rises through the switchgear compartments and is exhausted through the top air-exhaust ports, and replacement ambient air is drawn into the bottoms of the compartments through the air-intake ports.
    Type: Grant
    Filed: February 22, 2010
    Date of Patent: May 31, 2011
    Inventors: Gregory O. Motley, Dale Waynick, Eldridge R. Byron, Abraham de la Cruz
  • Publication number: 20100258532
    Abstract: An exhaust system for exhausting gases and molten debris caused by an electric arc within a switchgear. The exhaust system includes a switchgear having lower and upper compartments and an exhaust unit externally mounted to the switchgear. A wall panel of the switchgear includes blow out panels coinciding with openings in the lower compartment and corresponding ventilation flaps in a top surface of the exhaust unit to exhaust gas from the lower compartment out the blow out panels in a vertical direction, exiting through the flaps. The upper compartment includes ventilation flaps for exhausting gas in a vertical direction directly through the flaps and optionally through side-mounted blow out panels that communicate with the vertical vent path to the flaps in the top of the exhaust unit. A bus compartment in the exhaust unit includes a vent path to flaps in the top of the exhaust unit for exhausting gas produced by bus arcing.
    Type: Application
    Filed: April 8, 2009
    Publication date: October 14, 2010
    Inventors: Michael Miller, Abraham de la Cruz
  • Publication number: 20100087400
    Abstract: The present invention provides ?-hydroxy-?-aminophosphonates, ?-amino-?-aminophosphonates, and analogs thereof that inhibit carnitine acyltransferases. The invention also provides compositions comprising these ?-hydroxy-?-aminophosphonates, ?-amino-?-aminophosphonates, and analogs, and methods of the use of such compounds and compositions in the treatment, amelioration or prevention of pathological conditions, diseases or disorders that are linked with fatty acid metabolism, such as non-insulin dependent diabetes or obesity. The invention also provides processes for the preparation of such compounds and compositions.
    Type: Application
    Filed: October 8, 2009
    Publication date: April 8, 2010
    Applicant: Nucitec S.A. de C.V.
    Inventors: Ricardo Abraham De La Cruz Cordero, Miguel Angel Duarte Vázquez, Jorge Luis Rosado Loria